Women recovering from preeclampsia with elevated vascular biomarkers have a higher risk of future cardiovascular diseases. Benjamin H. Chi, MD, MSc, investigated whether HIV on treatment was associated with biomarkers of cardiovascular risk in the weeks following delivery.
Dr. Chi analyzed data from a six-month prospective cohort study conducted from January 2022 to June 2023. Women living with HIV on Antiretroviral Therapy (ART) had elevated hs-CRP but similar levels of other biomarkers after preeclampsia. Further studies are needed to explore the differential impact of HIV disease vs. antiretroviral treatment on inflammatory responses.